Our paper is finally out! We discovered that FAH is enriched in HR+ breast cancer where it drives treatment resistance via a novel non-canonical function
Jenny Hogstrom
@jennyhogstrom.bsky.social
Instructor in Medicine, Harvard Medical School. Co-director, Center for Patient-derived Models for Personalized Medicine at BIDMC
